rs1941404 5 amino 1mq 5-Amino-1MQ ensuring precise for reliable experimental outcomes. 5-Amino-1MQ | Synthesis Peptides
Description
Storage: 28C

| 2024 Edition 5-amino-1MQ shows great potential in the treatment of obesity and related metabolic disorders

Type: NNMT Enzyme Inhibitor

Peptides and Chronic Disease Peptides are increasingly recognized for their crucial role in the development and progression of chronic diseases such as diabetes and heart disease

Ethics declarations Competing interests SJW is the founder of Ridgeline Therapeutics, HN is a paid employee of Ridgeline Therapeutics and, since manuscript submission, ADW has also become a paid employee of Ridgeline Therapeutics
